Position in HUMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$852,500 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
2 quarters on record
Derivatives in HUMA
reported options exposure · as of Jun 30, 2026CallValue
$41,028
CallShares
52,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Asset Management Partners Inc. holds $46,847,679 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 322,467 | $42,801,044 | |||
| 2 | RNA |
Atrium Therapeutics, Inc.
|
150,000 | $2,017,500 | |
| 3 | RANI |
Rani Therapeutics Holdings, Inc.
|
2,318,542 | $1,762,091 | |
| 4 | EXEL |
Exelixis, Inc.
|
4,908 | $267,044 | |
| 5 | 1,150,300 | $0 | |||
| 6 | 320,529 | $0 | |||
| 7 | 360,000 | $0 | |||
| 8 | ASBP |
Aspire Biopharma Holdings, Inc.
|
138,536 | $0 |
All Filings in HUMA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,028 | 52,600 | Call | Sole | 2026-08-14 | |
| 2025-03-31 | $852,500 | 500,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||